AI assistant
Instil Bio, Inc. — Director's Dealing 2021
Mar 25, 2021
33728_dirs_2021-03-25_6c21ed4e-a174-4b4a-9d04-7ade95448b37.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-03-23
Reporting Person: Shah Nimish P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-23 | Common Stock | C | 5100866 | — | Acquired | 5100866 | Indirect |
| 2021-03-23 | Common Stock | C | 510030 | — | Acquired | 510030 | Indirect |
| 2021-03-23 | Common Stock | C | 430431 | — | Acquired | 5531297 | Indirect |
| 2021-03-23 | Common Stock | C | 43033 | — | Acquired | 553063 | Indirect |
| 2021-03-23 | Common Stock | C | 480716 | — | Acquired | 480716 | Indirect |
| 2021-03-23 | Common Stock | P | 104640 | $20.00 | Acquired | 5635937 | Indirect |
| 2021-03-23 | Common Stock | P | 10470 | $20.00 | Acquired | 563533 | Indirect |
| 2021-03-23 | Common Stock | P | 116880 | $20.00 | Acquired | 597596 | Indirect |
| 2021-03-23 | Common Stock | P | 48390 | $20.00 | Acquired | 48390 | Indirect |
| 2021-03-23 | Common Stock | P | 19620 | $20.00 | Acquired | 19620 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-23 | Series B Preferred Stock | $ | C | 4250722 | Disposed | Common Stock (5100866) | Indirect | |
| 2021-03-23 | Series B Preferred Stock | $ | C | 425025 | Disposed | Common Stock (510030) | Indirect | |
| 2021-03-23 | Series C Preferred Stock | $ | C | 358693 | Disposed | Common Stock (430431) | Indirect | |
| 2021-03-23 | Series C Preferred Stock | $ | C | 35861 | Disposed | Common Stock (43033) | Indirect | |
| 2021-03-23 | Series C Preferred Stock | $ | C | 400597 | Disposed | Common Stock (480716) | Indirect |
Footnotes
F1: Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common
Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date.
F2: The securities are held by Venrock Healthcare Capital Partners III, L.P. ("Partners III"). VHCP Management III, LLC ("Management III") is the
sole general partner of Partners III. The Reporting Person is a voting member of Management III and may be deemed to share voting and
investment power with respect to the shares held by Partners III and disclaims Section 16 beneficial ownership of such securities held by
Partners III, except to the extent of his pecuniary interest therein, if any.
F3: The shares are held by VHCP Co-Investment Holdings III, LLC ("Holdings III"). Management III is the manager of Holdings III. The Reporting
Person is a voting member of Management III and may be deemed to share voting and investment power with respect to the shares held by
Holdings III and disclaims Section 16 beneficial ownership of such securities held by Holdings III, except to the extent of his pecuniary interest
therein, if any.
F4: The securities are held by Venrock Healthcare Capital Partners EG, L.P. ("Partners EG"). VHCP Management EG, LLC ("Management EG") is
the sole general partner of Partners EG. The Reporting Person is a voting member of Management EG and may be deemed to share voting and
investment power with respect to the shares held by Partners EG and disclaims Section 16 beneficial ownership of such securities held by
Partners EG, except to the extent of his pecuniary interest therein, if any.
F5: The securities are held by Venrock Healthcare Capital Partners II, L.P. ("Partners II"). VHCP Management II, LLC ("Management II") is the sole general partner of Partners II. The Reporting Person is a voting member of Management II and may be deemed to share voting and investment power with respect to the shares held by Partners II and disclaims Section 16 beneficial ownership of such securities held by Partners II, except to the extent of his pecuniary interest therein, if any.
F6: The shares are held by VHCP Co-Investment Holdings II, LLC ("Holdings II"). Management II is the manager of Holdings II. The Reporting Person is a voting member of Management II and may be deemed to share voting and investment power with respect to the shares held by Holdings II and disclaims Section 16 beneficial ownership of such securities held by Holdings II, except to the extent of his pecuniary interest therein, if any.